Podnosis
196 clip(s) in playlist
How MRD Testing Is Reshaping Breast Cancer Risk Assessment (Sponsored)
In this sponsored episode of Podnosis, experts examine how molecular residual disease testing is transforming how clinicians assess recurrence risk in triple-negative breast cancer. Drawing on new data from the NSABP B-59 substudy presented at SABCS and AACR, the discussion highlights how circulati…
09:28
The push to expand access to emergency contraception
Condoms can be purchased almost anywhere, from big retailers to small convenience stores. The same can’t be said for female birth control. One company is trying to change that. Cadence OTC sells the morning-after pill, a cheaper alternative to Plan B. Recognizing that many communities in the U.S. …
27:08
Why UnitedHealth Group is betting big on doulas
Maternal and infant health remains a significant challenge across the country. To support better outcomes for both pregnant women and their babies, industry giant UnitedHealth Group is investing in doulas. Its insurance arm recently expanded a doula support program nationwide in its employer plans.…
17:46
One man’s journey from gambling addiction to recovery and advocacy
Mike Sciandra grew up around gamblers. It wasn’t long before he became one. He gambled for more than 20 years, declaring bankruptcy twice. He knew he had a problem, but it wasn’t until he entered treatment that he realized it was a gambling addiction. In today’s episode, you’ll hear Sciandra tell …
28:49
How CVS Caremark is using innovative technology to simplify the prior authorization process (Sponsored)
Prior authorization is often cited as a major pain point in healthcare—but it doesn’t have to be. In this conversation, Dr. Michelle Gourdine, Chief Medical Officer at CVS Caremark, shares how Caremark is transforming the prior authorization experience through automation, clinical rigor and respons…
10:40Clean
Shadow AI: Dos and don’ts for healthcare orgs
How many doctors are using AI tools in a healthcare setting? It’s a question everyone wants answered, and one that’s impossible to pin down exactly. But recent data may offer a clue. Wolters Kluwer, which creates evidence-based clinical decision support tools for physicians, conducted a survey of …
27:11
Clinicians are burnt out. Peer support can help
The COVID-19 pandemic spotlighted burnout in healthcare. While not new, the challenge was compounded by the toll of caring for patients on the frontlines. Burnout rates have swelled since then, and addressing them is not simple. A recent Johnson & Johnson survey of more than 1,500 surgeons across …
23:17
The evolving state of exome and genome sequencing
Rare diseases, defined in the U.S. as conditions affecting fewer than 200,000 people, can take years, if not decades, to diagnose. About 10,000 rare diseases affect 30 million Americans, and half of those patients are children. What if rare diseases could be identified early and treated proactivel…
25:55
How CVS Caremark is shaping the future of pharmacy benefits (Sponsored)
In this sponsored episode of Podnosis, CVS Caremark Senior Vice President and Chief Growth Client Success Officer James Margiotta joins host Chris Hayden for an in‑depth look at the rapidly changing pharmacy benefits landscape. Drawing on more than 35 years across payer, PBM, pharmacy and healthcar…
29:21Clean
Inside the economics of emergency medicine
Emergency departments are required by law to treat anyone who comes through the door. But the financial model behind that guarantee is under strain. In this episode of "Podnosis," Fierce Healthcare and Life Sciences Editor-in-Chief Ayla Ellison talks with Tony Cirillo, M.D., president of the Amer…
18:35